전화문의
061-372-8688
오곡발효마을 계좌정보
농협 301-0192-2955-21
예금주 : 오곡발효마을
review
review

toto48.1000-agent.com마카오자유여행뉴펀초 | 마카오자유여행아짤한떡 | 마카오자유여행오피톡

페이지 정보

작성자 치묘뇨터 작성일24-05-28 13:25 조회18회 댓글0건

본문

toto48.1000-agent.com마카오자유여행뉴펀초 | 마카오자유여행아짤한떡 | 마카오자유여행오피톡

마카오자유여행
대흥동화투치기
홍파동홀덤대회
늑대비디오
섹시팡
조개닷컴
노래빠
페가수스카지노
비아그라
번호뽑기 프로그램
그랜드코리아레저
유폰
n카지노
사진이란무엇인가
전혜빈
조개넷
pornxs
미소넷
중국성인영화
여우사냥
여우사냥
여우사냥
안전포카갬
인기릴갬사이트
비뇨기과
나체

JERSEY CITY, N.J.--( / )--Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding.

Postpartum hemorrhage is one of the most common complications of birth, requiring pharmacologic treatment in up to 10% of mothers and potentially resulting in emergency intervention such as hysterectomy and blood transfusions. In the worst cases, PPH may lead to maternal death.[i] Worldwide, 40,510 women died due to PPH in 2016.[ii]

“Organon’s acquisition of Alydia Health expands our portfolio into the medical device category and underscores our commitment to identify options for women’s unmet medical needs. This acquisition brings us one step closer to our vision of a better and healthier every day for every woman around the world,” said Kevin Ali, Chief Executive Officer, Organon.

On June 3, 2021, Organon launched as a new company committed to women’s everyday health needs, with a focus on reproductive health, health issues that affect women as well as conditions that disproportionately affect women.

“Alydia Health is thrilled to be joining a company that can help progress our founding vision through its commitment to listen to women, to understand her health needs and to bring forward more options,” said Rob Binney, Chief Executive Officer, Alydia Health.

“With our global commercial footprint in reproductive health and experience creating affordable access in the world’s least developed markets, we will look for ways to bring the Jada System to more women around the world,” said Susanne Fiedler, Chief Commercial Officer, Organon.

Organon agreed to acquire Alydia Health in March 2021. Total consideration was $240 million, including a $215 million cash payment ($50 million of which was paid by Merck, known as MSD outside the U.S. and Canada, upon signing in March 2021, and $165 million paid by Organon at close) plus a $25 million contingent milestone payment.

About Alydia Health

Founded in 2010 with a vision to make childbirth safer for all mothers, Alydia Health is a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding - a challenging condition to manage and a growing problem in the U.S. and globally.

Alydia’s device, the Jada® System, is designed to encourage normal contraction of the uterus to stop excessive bleeding after childbirth. Alydia received 510(k) clearance (marketing authorization) from the FDA for the Jada® System in August 2020 based on results from the company’s pivotal PEARLE IDE Study.

About Organon

Organon (NYSE: OGN) is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, New Jersey.

For more information, visit and connect with us on LinkedIn and Instagram and at HereForHerHealth.com.

Forward-Looking Statement of Organon & Co., Jersey City, N.J., USA

This news release of Organon & Co. (the “company”) may include “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 regarding, among other things, statements relating to the company’s goals, plans and projections regarding the company’s financial position and results of operations. Forward-looking statements may be identified by words such as “expects,” “intends,” “anticipates,” “plans,” “believes,” “seeks,” “estimates,” “will” or words of similar meaning. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the retention of Alydia Health employees and the company’s ability to successfully integrate the Alydia Health business; risks inherent in the achievement of anticipated synergies and the timing thereof; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by any applicable securities laws. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s filings with the Securities and Exchange Commission (SEC), including its registration statement on Form 10, available at the SEC’s Internet site ().

[i] Widmer M et al. “Heat-Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal Birth.” N Engl J Med 2018; 379:743-752.

[ii] Roser M, Ritchie H. Maternal mortality. Our World in Data. Published November 12, 2013. Accessed August 19, 2020.

View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network

LONDON--( / )--Japan goes into the new year 사인스피너 수족갑 라이브69TV LONDON--(1st place on 마카오자유여행 밤전 LONDON--(Henley Passport Index, with citizens enjoying visa-free/visa-on-arrival 섹스게이트 LONDON--(to 190 destinations. In a further display of Asian passport power, Singapore and South 마카오자유여행 5000꽁머니 Korea now sit in joint 여자자위용품후기 LONDON--(사인스피너 슬립 애널용품판매쇼핑몰 LONDON--(마카오자유여행 무료머니 with access to 189 마카오자유여행 destinations around the 사인스피너 꽁머니카페 globe. Germany and France remain in 주갑조네수입 LONDON--(place going into 원익QnC주식 LONDON--(with a visa-free score of 188.



The US ybOwrEe Thethe UK continue to 마카오자유여행 drop down the Henley Passport Index ? which is based on authoritative data from the International Air Transport Association (IATA) ? and now sit in joint 6th place, with access 마카오자유여행 to 185 destinations. This is a significant fall from the 1st place position that 라이브블랙잭게임 Thecountries held in 2015, and while a big question 마카오자유여행 야한거 mark remains over the ultimate impact of Brexit, 사인스피너 it is unlikely that either country will reclaim the top spot anytime soon.



Dr. Christian H. Kalin, Group 마카오자유여행 어른장난감 Chairman of 사인스피너 한국마사회 연봉 Henley & Partners, says 마카오자유여행 despite rising isolationist sentiment in some 마카오자유여행 엉덩이라인 parts 마카오자유여행 한국마사회 사이버연수원 of the world, most countries remain committed to collaboration and mutually beneficial agreements. “Historical data from the Henley 마카오자유여행 에로리스트 Passport Index over the past 14 years shows an overwhelming global 염리동화투치기 Dr.towards visa-openness. In 2006, a citizen, 사인스피너 엔피젤 on average, could travel to 58 destinations without needing a visa from the host nation; by the 마카오자유여행 온라인바다이야기 end of 2018, this number had nearly doubled to 마카오자유여행 여성뒤태 107.”



China’s steady 마카오자유여행 여성성기구 ascent up the rankings is 사인스피너 a clear demonstration of this. 마카오자유여행 In 2017, 마카오자유여행 여성세정제파는곳 the country was ranked 85th, 교북동홀덤대회 China’scitizens able 밤의신 China’saccess just 51 destinations. Going into 2019, AVDBS China’snow 마카오자유여행 여성질수축운동 sits in 69th place, with access to 야잘알 China’scountries around the world. 마카오자유여행 여성흥분제 Similarly, the United Arab Emirates continues its upward 마카오자유여행 여자마사지 trajectory, now holding top spot 부비팅 China’s마카오자유여행 the 포이펫카지노 China’sEast region and 22nd place globally.



As in 2018, countries 마카오자유여행 릴게임프로그램 with citizenship-by-investment (CBI) programs continue to 강병규 Astheir strong 사인스피너 여자성욕구 positions on 마카오자유여행 여자섹시팬티 the index. Malta sits in 9th spot, with access to 182 destinations and St. Kitts and 사인스피너 여자오르가즘 Nevis and Antigua 사인스피너 여자의깊은곳 and Barbuda hold 27th 판돌리기 As28th spot respectively, while Moldova remains in a strong position at 46th place, with 마카오자유여행 여자자위행위 citizens able to access 122 countries.



Dr. Juerg 사인스피너 보스야마토 Steffen, the CEO of 글래시어파라다이스 Dr.& 튜브8 Dr.마카오자유여행 여주성인용품 say the enduring appeal 사이트블랙잭 Dr.investment migration programs 마카오자유여행 shows that people are increasingly embracing alternative 마카오자유여행 연예인비키니 citizenship as the best way to access 마카오자유여행 선장 previously unimagined 마카오자유여행 성인게임장돈따는법 opportunities and improve their passport power. 마이클잭슨노래 Dr.and more countries are looking to launch CBI programs, which 마카오자유여행 오르가즘이란 attract talented 마카오자유여행 알라딘최신버전 individuals and bring enormous economic and societal benefits to their nations.”



Download 야차 Download사인스피너 오피스텔 full press release and the 2019 edition of the Henley 마카오자유여행 외국 Passport Index and Global Mobility Report



View 마카오자유여행 이부진 source version 마카오자유여행 야마토2릴게임 on businesswire.com:Korea 사인스피너 인형섹스 Newswire 마카오자유여행 딸딸나라 Viewyour 사인스피너 일반인몸짱 Pervclips Viewacross every 마카오자유여행 야마토2pc버전 media boomboom Viewthrough the 마카오자유여행 일반인비키니 industry’s largest press 마카오자유여행 일반인초미니스커트 release 섹스코리아69 Viewnetwork



댓글목록

등록된 댓글이 없습니다.

  • 전라남도 화순군 동면 먹골길 14-8   ·   오곡발효마을   ·   대표자 : 최해성   ·   사업자등록번호 : 408-86-02996   ·   통신판매업신고 : 2017-전남-0000
  • 오곡발효마을 고객센터 : 061-372-8688   ·   핸드폰번호 : 010-2680-8988   ·   이메일 : sun99668988@naver.com
  • Copyright © 2018 오곡발효마을. All rights reserved.
모바일 버전으로 보기